Brief: DiaMedica Therapeutics Announces Publication Of Dm199’S Mechanism Of Action For The Treatment Of Acute Ischemic Stroke In The Journal Stroke
20/02/2025 13:31
Feb 20 (Reuters) - DiaMedica Therapeutics Inc DMAC.O :
* DIAMEDICA THERAPEUTICS ANNOUNCES PUBLICATION OF DM199’S
MECHANISM OF ACTION FOR THE TREATMENT OF ACUTE ISCHEMIC STROKE
(AIS) IN THE JOURNAL STROKE
Source text: ID:nBw6N9Q4na
Further company coverage: DMAC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DiaMedica Therapeutics
See all newsBrief: Diamedica Therapeutics Announces Enrollment Of 200Th Patient In Remedy2 Phase 2/3 Acute Ischemic Stroke Trial
DiaMedica Q2 net loss widen less than expected
DiaMedica Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood
Brief: Diamedica Receives FDA Feedback On Dm199 Preeclampsia Nonclinical Program